MicuraPharm demo center handover of keys
The key to the demo center was ceremoniously handed over to pharmacist Kristina Gand from Mainz. In future, she will produce cup blisters here fully automatically.
Now that MicuraPharm GmbH has successfully moved into its new company building in June 2023, the next milestone is about to be reached:
In future, under the management of pharmacist Kristina Gand from the Rathaus-Apotheke Mainz-Finthen, the first fully automated system
for patient-specific blistering will be operated in the MicuraPharm demo center.
The D³ Daily Dose Dispenser from KNAPP was developed in collaboration with the logistics company from Graz
and will be delivered in 2024. The prototype has already moved into the demo center in Klein-Winternheim.
"With this innovation, we are revolutionizing the individual supply of medication
chronically ill patients," summarizes CEO Edgar Mähringer-Kunz
at the key handover ceremony.
The blister packaging process has become a major challenge for pharmacies, particularly in view of the increasing number of patients who require an individual medication plan. "The D³ Daily Dose Dispenser manages the pills itself. The medication remains in its original blister until it is immediately filled," says CEO Edgar Mähringer-Kunz, adding, "The system does all of this at high speed and with maximum safety." The individual work steps are automatically checked and documented in the system. The smallest version of the D³ Daily Dose Dispenser from KNAPP can be operated by one operator and can produce up to 1,500 weekly blisters. Thanks to its modularity, up to 4,500 patients can be supplied with weekly blisters with a single system.
This allows the D³ Daily Dose Dispenser to adapt to the growth of the pharmacy. For Kristina Gand and her mother Josefine Kros, who run a total of six pharmacies under the name Apothekenfamilie Mainz, the fully automated blister packaging system heralds a new era.
In the future, she will be able to supply several thousand patients via the demo center. The 213 m² site in Klein-Winternheim houses the D³ Daily Dose Dispenser with two production lines. From the delivery of medication to the production of patient blister packs and delivery, the entire process is carried out from the demo center.
On the occasion of the celebrations, the State Secretary of Rhineland-Palatinate, Petra Dick-Walther, also expressed her congratulations and saw the D³ Daily Dose Dispenser for herself: "Cooperation like this, between MicuraPharm and KNAPP AG, means progress and innovation. Such innovative solutions are needed to meet the challenge of the current shortage of nursing staff, together with the demographic development of the population, and at the same time to improve the safety of taking medication."
Following the handover of the keys, the coming months at MicuraPharm will be focused on validation. The validation documents have been prepared and testing has begun. As soon as validation has been successfully completed, Kristina Gand will be the first pharmacist in Germany to start production of the fully automated cup blisters.